More recently, a study identified the pathogenic behavior of eukaryotic elongation factor-2 (eEF2K) in RA where the inhibition of eEF2k suppressed the glycolysis in RA [87]. The gene discussed is EEF2K; the disease is rheumatoid arthritis.